MassArray and Related Sales Push Sequenom's Q1 Revenues up 43 Percent | GenomeWeb
NEW YORK (GenomeWeb News) - Sequenom yesterday said first-quarter revenue surged 43 percent as R&D spending increased 17 percent and net loss was stable. 
 
Total receipts for the three months ended March 31, 2007, rose to $9.9 million from $6.9 million year over year.
 
The company said the jump in revenues was driven mainly by sales of MassArray instruments and related products, and by growth in its contract research services group.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.